VITASOY INT'L(VTSYY)
Search documents
维他奶国际(00345) - 翌日披露报表

2025-11-28 08:57
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 維他奶國際集團有限公司 呈交日期: 2025年11月28日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現有已發 行股份(不包括 ...
VITASOYINT'L(00345.HK)11月27日回购2592.67万港元,年内累计回购3.31亿港元

Zheng Quan Shi Bao Wang· 2025-11-27 15:13
Core Points - VITASOY INT'L has conducted share buybacks, repurchasing 3.952 million shares at prices ranging from HKD 6.480 to HKD 6.700, totaling HKD 25.93 million on November 27 [2] - The stock closed at HKD 6.500 on the same day, reflecting a decline of 3.13%, with a total trading volume of HKD 54.96 million [2] - Since November 26, the company has repurchased a total of 7.914 million shares, amounting to HKD 52.55 million, during which the stock has decreased by 2.69% [2] Buyback Summary - Year-to-date, VITASOY INT'L has executed 48 buybacks, totaling 38.36 million shares and an aggregate buyback amount of HKD 331 million [3] - Detailed buyback transactions include: - November 27: 395.20 thousand shares at a maximum price of HKD 6.700 and a minimum price of HKD 6.480, totaling HKD 25.93 million [3] - November 26: 396.20 thousand shares at a maximum price of HKD 6.790 and a minimum price of HKD 6.510, totaling HKD 26.62 million [3] - Other notable buybacks occurred on October 22, October 21, and earlier dates, with varying amounts and prices [4]
受困传统零售 维他奶国际降价寻增
Bei Jing Shang Bao· 2025-11-27 14:26
Core Viewpoint - Vitasoy International reported a 6% decline in revenue for the first half of the 2025/2026 fiscal year, primarily due to a weak market and intensified competition in the plant-based milk sector, posing challenges for the company's growth [2] Revenue Performance - The company's revenue for the first half of the fiscal year was HKD 3.227 billion, down from the previous year [2] - Revenue from mainland China decreased by 9.19% to HKD 1.778 billion, while net profit fell by 12.45% to HKD 192 million [3] - Mainland China accounts for approximately 55% of Vitasoy's total revenue and 63.07% of its net profit [3] Strategic Initiatives - To counteract declining sales, Vitasoy implemented cost optimization measures, maintaining an operating profit margin of 11% in mainland China [3] - The company introduced innovative products like the "Vitasoy Lemon Tea" to enhance its market share in the ready-to-drink tea category [3] - A price reduction of 10%-15% for Vitasoy Lemon Tea was attempted to respond to industry price wars, resulting in increased market share [3] Market Challenges - Vitasoy's business in Hong Kong also faced growth pressures, with a 4% revenue decline attributed to weak performance in its Vitasoy Tian Di business and adverse weather conditions affecting sales [4] - The company continues to hold a leading position in the non-alcoholic beverage market in Hong Kong, supported by successful product launches [4] Long-term Outlook - Despite short-term challenges, the company remains confident in its long-term growth potential, aiming to increase the proportion of low-sugar or no-added-sugar products to 80% by the 2030/2031 fiscal year [5] - The company is focusing on expanding its presence in southern China and Southeast Asia to capture growth opportunities [6]
受困传统零售,维他奶国际降价寻增
Bei Jing Shang Bao· 2025-11-27 14:13
Core Viewpoint - Vitasoy International reported a 6% decline in revenue for the first half of the 2025/2026 fiscal year, totaling HKD 3.227 billion, primarily due to a weak market and intensified competition in the plant-based milk sector [1] Revenue Performance - Revenue from mainland China decreased by 9.19% to HKD 1.778 billion, while net profit fell by 12.45% to HKD 192 million, with mainland China accounting for approximately 55% of total revenue and 63.07% of net profit [3] - The overall revenue decline was attributed to a contraction in traditional retail channels, despite maintaining an operating profit margin of 11% through cost optimization measures [4] Product Strategy - Vitasoy introduced innovative products like the "Vitasoy Lemon Tea" to enhance market share in the ready-to-drink tea category amid slowing growth in plant-based and tea products [4] - A price reduction of approximately 10%-15% for Vitasoy Lemon Tea was implemented to respond to industry price wars, resulting in increased market share [4] Market Challenges - The Hong Kong business also faced growth pressures, with a 4% revenue decline attributed to weak performance in Vitasoy's subsidiary, Macau, and export markets [5] - Adverse weather conditions during the typhoon season negatively impacted business operations, particularly in the Vitasoy subsidiary [5] Competitive Landscape - Vitasoy faces significant competition from companies like Mengniu, Yili, and DaLi Foods, which have launched their own soy milk products, as well as the rise of sugar-free tea and ready-to-drink brands that compete with Vitasoy's offerings [6] - The company plans to increase the proportion of low-sugar or no-added-sugar products to 80% by the 2030/2031 fiscal year to align with health-conscious consumer trends [6] Future Outlook - Analysts suggest that Vitasoy's focus on cost reduction and efficiency improvements, along with potential market opportunities in southern China and Southeast Asia, could support future growth [7]
VITASOY INT"L(00345.HK)11月27日耗资2592.67万港元回购395.2万股

Jin Rong Jie· 2025-11-27 11:20
格隆汇11月27日丨VITASOY INT'L(00345.HK)发布公告,2025年11月27日耗资2592.67万港元回购395.2 万股,回购价格每股6.48-6.7港元。 本文源自:格隆汇 ...
VITASOY INT‘L(00345)11月27日斥资2592.67万港元回购395.2万股

Zhi Tong Cai Jing· 2025-11-27 09:47
智通财经APP讯,VITASOY INT'L(00345)发布公告,于2025年11月27日斥资2592.67万港元回购395.2万 股。 (原标题:VITASOY INT'L(00345)11月27日斥资2592.67万港元回购395.2万股) ...
维他奶国际(00345) - 翌日披露报表

2025-11-27 08:58
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 維他奶國際集團有限公司 呈交日期: 2025年11月27日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | | 佔 ...
维他奶国际跌超3% 上半财年内地业务面临挑战 麦格理下调公司目标价
Zhi Tong Cai Jing· 2025-11-27 07:45
Core Viewpoint - Vitasoy International (00345) experienced a decline of over 3%, with a current price of HKD 6.5 and a trading volume of HKD 43.68 million [1] Financial Performance - For the six months ending September 30, 2025, Vitasoy reported revenue of HKD 3.227 billion, a decrease of 6% year-on-year [1] - Gross profit was HKD 1.648 billion, down 7% compared to the previous year [1] - Profit attributable to equity holders was HKD 172 million, reflecting a year-on-year increase of 1% [1] Market Challenges - The revenue decline is primarily attributed to weak market conditions affecting the mainland China business, which is facing significant challenges [1] Analyst Adjustments - Macquarie has revised its net profit forecasts for Vitasoy for the fiscal years 2026 and 2027, lowering them by 16.3% and 13.3% respectively [1] - The target price for Vitasoy has been reduced from HKD 10 to HKD 7.4, while maintaining an "outperform" rating [1]
港股异动 | 维他奶国际(00345)跌超3% 上半财年内地业务面临挑战 麦格理下调公司目标价
Zhi Tong Cai Jing· 2025-11-27 07:45
Core Viewpoint - Vitasoy International (00345) has faced challenges in its mainland China business, leading to a decline in revenue and a drop in stock price by over 3% [1] Financial Performance - For the six months ending September 30, 2025, Vitasoy reported revenue of HKD 3.227 billion, a decrease of 6% year-on-year [1] - Gross profit was HKD 1.648 billion, down 7% compared to the previous year [1] - Profit attributable to equity holders was HKD 172 million, reflecting a year-on-year increase of 1% [1] Market Analysis - The decline in revenue is primarily attributed to weak market conditions in mainland China, which has posed significant challenges for the company's performance [1] - Macquarie has revised its profit forecasts for Vitasoy, lowering the net profit estimates for fiscal years 2026 and 2027 by 16.3% and 13.3%, respectively [1] - The target price for Vitasoy's stock has been reduced from HKD 10 to HKD 7.4, while maintaining an "outperform" rating [1]
VITASOYINT'L(00345.HK)11月26日回购2662.46万港元,年内累计回购3.05亿港元

Zheng Quan Shi Bao Wang· 2025-11-26 15:16
Summary of VITASOY INT'L Buyback Activity Core Viewpoint - VITASOY INT'L has been actively repurchasing its shares, indicating a strategy to enhance shareholder value and confidence in its stock performance. Buyback Details - On November 26, 2025, VITASOY INT'L repurchased 3.962 million shares at a price range of HKD 6.510 to HKD 6.790, totaling HKD 26.6246 million [2] - The stock closed at HKD 6.710 on the same day, reflecting a 0.45% increase with a total trading volume of HKD 71.3114 million [2] - Year-to-date, the company has conducted 47 buyback transactions, acquiring a total of 34.408 million shares for an aggregate amount of HKD 305 million [2] Historical Buyback Data - The buyback activity includes various transactions with the highest repurchase price recorded at HKD 9.700 and the lowest at HKD 6.510 [2][3] - Notable buyback transactions include: - 200,000 shares at HKD 9.700 on April 25, 2025 [3] - 184,400 shares at HKD 9.170 on August 1, 2025 [3] - 396,200 shares at HKD 6.790 on November 26, 2025 [2]